Ho Maykin

Biomarin Pharmaceutical Inc · Director

Ho Maykin is listed in public filings as director. This Ho Maykin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Biomarin Pharmaceutical Inc (BMRN), Neumora Therapeutics, Inc. Common Stock (NMRA), Agios Pharmaceuticals, Inc. - Common Stock (AGIO) (AGIO), and Kyntra Bio, Inc. (KYNB). Investors use Ho Maykin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Biomarin Pharmaceutical IncBMRN--35.5k sharesGrant / ExerciseJun 2, 2026Disclosure amount unavailable7.5k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Neumora Therapeutics, Inc. Common StockNMRA$149k80k sharesGrant / ExerciseMay 27, 2026$148.8K80k shares$1.86--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO--2.1k sharesGrant / ExerciseJun 20, 2025Disclosure amount unavailable2.1k shares----
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO$560k15.8k sharesGrant / ExerciseJun 18, 2025$559.8K15.8k shares$35.50--
Agios Pharmaceuticals, Inc. - Common Stock (AGIO)AGIO--2.8k sharesGrant / ExerciseJun 18, 2025Disclosure amount unavailable2.8k shares----
Kyntra Bio, Inc.KYNB$37k120k sharesGrant / ExerciseJun 4, 2025$36.6K120k shares$0.3051--
Neumora Therapeutics, Inc. Common StockNMRA$69k95.6k sharesGrant / ExerciseMay 28, 2025$68.8K95.6k shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$58k80k sharesGrant / ExerciseMay 28, 2025$57.6K80k shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$028.6k sharesOtherMay 28, 2025$48.3K28.6k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$21k28.6k sharesGrant / ExerciseMay 28, 2025$20.6K28.6k shares$0.72--
Neumora Therapeutics, Inc. Common StockNMRA$20k27.8k sharesGrant / ExerciseMay 28, 2025$20.0K27.8k shares$0.72--
Biomarin Pharmaceutical IncBMRN--28k sharesGrant / ExerciseMay 20, 2025Disclosure amount unavailable6.7k shares----
Neumora Therapeutics, Inc. Common StockNMRA$027.8k sharesOtherFeb 13, 2025$472.6K27.8k shares$17.00--
Neumora Therapeutics, Inc. Common StockNMRA$028.6k sharesOtherFeb 13, 2025$284.3K28.6k shares$9.95--
Neumora Therapeutics, Inc. Common StockNMRA$095.6k sharesOtherFeb 13, 2025$239.9K95.6k shares$2.51--
Neumora Therapeutics, Inc. Common StockNMRA$162k95.6k sharesGrant / ExerciseFeb 13, 2025$161.5K95.6k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$48k28.6k sharesGrant / ExerciseFeb 13, 2025$48.3K28.6k shares$1.69--
Neumora Therapeutics, Inc. Common StockNMRA$47k27.8k sharesGrant / ExerciseFeb 13, 2025$47.0K27.8k shares$1.69--
Ho Maykin | TradingNote